文献速递骨肿瘤

传统软骨肉瘤分期中骨骼影像学检查是否必要?

Is Skeletal Imaging Essential in the Staging Workup for Conventional Chondrosarcoma?
PubMed 文献 · Clin Orthop Relat Res · 2020-01-01

本研究回顾性分析427例经组织学证实的传统软骨肉瘤患者,评估骨骼转移的发生比例。结果显示仅3例2级患者有孤立骨骼转移,无1级或3级患者出现骨转移,提示骨骼扫描在常规分期中可能过度使用,或可考虑省略,仅保留给有肺转移的患者。

要点

  • 传统软骨肉瘤骨骼转移发生率极低,仅见于少数2级患者。
  • 无1级或3级患者检出骨转移,骨骼扫描在分期中可能过度使用。
  • 建议考虑省略常规骨骼影像学检查,或仅用于已确诊肺转移者。

核心结论

  • 传统软骨肉瘤骨骼转移发生率极低,骨骼扫描在现行分期流程中可能过度使用,应考虑省略,或仅保留给有肺转移的患者。

主要发现

  • 427例中,35例(8%)在初始分期时发现孤立肺转移,包括330例2级中的31例(9%)和41例3级中的4例(10%),1级患者无肺转移。
  • 仅3例2级软骨肉瘤患者有孤立骨骼转移,1级和3级患者均未检出骨转移。
  • 仅2例2级软骨肉瘤患者同时有肺和骨转移。

关键数值与推荐

  • 所有患者均接受胸部CT和骨扫描或全身FDG PET/CT进行分期。

临床怎么用

  • 对于传统软骨肉瘤,可考虑省略常规骨骼影像学分期检查,或仅对已确诊肺转移的患者进行骨骼扫描。

局限性

  • 缺乏生存结局数据,无法确定在无症状情况下检出少数骨骼病变的重要性。
  • 为回顾性研究,证据等级为Level IV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staging of a bone sarcoma before initiating treatment helps orthopaedic oncologists determine the intent of treatment and predicting the prognosis. As per National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) guidelines, there are no exclusive recommendations for chondrosarcoma staging. They are staged similar to other bone sarcomas even though skeletal metastases are extremely rare in chondrosarcomas. QUESTIONS/PURPOSES: We asked: (1) What proportion of patients with a chondrosarcoma present with detectable only skeletal metastasis? (2) What proportion of patients with chondrosarcoma present with skeletal metastasis with or without concurrent pulmonary metastases? METHODS: Between January 2006 to December 2017, 480 patients with histology-proven chondrosarcomas of the extremity, including clavicle, scapula, spine, and pelvis, presented to our institute. Fifty-three patients were excluded due to incomplete details about their staging. The remaining 427 were retrospectively analyzed and included in this study. Their clinical, radiological, and histopathological details were retrieved from patient files and electronic medical records. Of the 427 patients included, 53 had Grade 1 chondrosarcoma, 330 had Grade 2 chondrosarcoma, and 41 had Grade 3 chondrosarcoma. Grade was not available in three patients. All patients were staged with a thoracic CT scan and bone scan or a whole body fluorodeoxyglucose positron-emission tomography/CT (FDG PET/CT). Patients with a suspected or documented metastasis were reviewed again by an experienced radiologist and a nuclear medicine expert for the purpose of this study. A total of 8% (35 of 427) of patients with chondrosarcoma had isolated lung metastases at the time of initial staging. These included 9% (31 of 330) of patients with Grade 2 chondrosarcomas and 10% (4 of 41) of patients with Grade 3 chondrosarcomas. No patient with a Grade 1 chondrosarcoma had detectable lung metastases. The primary study endpoint was the number of patients who had a diagnosis of skeletal or skeletal and lung metastases as identified by the staging modalities. RESULTS: Three patients with Grade 2 chondrosarcoma had only skeletal metastasis. No patients with Grade 1 or Grade 3 chondrosarcoma had detectable bone metastases. Combined lung and bone metastases were seen in only two patients with Grade 2 chondrosarcoma. CONCLUSIONS: Our study found that the incidence of bony metastasis in conventional chondrosarcomas is extremely low. Considering the present results, we believe skeletal scanning may be overused in current staging algorithms. We do not have survival outcomes to know if detecting these few patients with skeletal lesions at initial presentation would be important in the absence of symptoms, but our data suggest that omitting skeletal imaging from the staging work-up of conventional chondrosarcomas should be considered. It may be reserved for patients with documented pulmonary metastases. LEVEL OF EVIDENCE: Level IV, diagnostic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Gulia A, Kurisunkal V, Puri A, et al. Is Skeletal Imaging Essential in the Staging Workup for Conventional Chondrosarcoma? Clin Orthop Relat Res. 2020. PMID: 32567825. doi:10.1097/CORR.0000000000001357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。